Thousands of missed genes found in bacterial genomes and their analysis with COMBREX by Wood, Derrick E et al.
Wood et al. Biology Direct 2012, 7:37
http://www.biology-direct.com/content/7/1/37RESEARCH Open AccessThousands of missed genes found in bacterial
genomes and their analysis with COMBREX
Derrick E Wood1,2,3*†, Henry Lin2†, Ami Levy-Moonshine4†, Rajiswari Swaminathan4, Yi-Chien Chang5,
Brian P Anton6, Lais Osmani4, Martin Steffen4,7, Simon Kasif4,5 and Steven L Salzberg3,8Abstract
Background: The dramatic reduction in the cost of sequencing has allowed many researchers to join in the effort
of sequencing and annotating prokaryotic genomes. Annotation methods vary considerably and may fail to identify
some genes. Here we draw attention to a large number of likely genes missing from annotations using common
tools such as Glimmer and BLAST.
Results: By analyzing 1,474 prokaryotic genome annotations in GenBank, we identify 13,602 likely missed genes
that are homologs to non-hypothetical proteins, and 11,792 likely missed genes that are homologs only to
hypothetical proteins, yet have supporting evidence of their protein-coding nature from COMBREX, a newly created
gene function database. We also estimate the likelihood that each potential missing gene found is a genuine
protein-coding gene using COMBREX.
Conclusions: Our analysis of the causes of missed genes suggests that larger annotation centers tend to produce
annotations with fewer missed genes than smaller centers, and many of the missed genes are short genes <300
bp. Over 1,000 of the likely missed genes could be associated with phenotype information available in COMBREX.
359 of these genes, found in pathogenic organisms, may be potential targets for pharmaceutical research.
The newly identified genes are available on COMBREX’s website.
Reviewers: This article was reviewed by Daniel Haft, Arcady Mushegian, and M. Pilar Francino (nominated by
David Ardell).Background
Bacterial gene identification has improved considerably
since the first bacterial genome, Haemophilus influenzae
Rd KW20, was sequenced in 1995 [1]. Bacterial genome
annotation is usually done through an automated
process that identifies most genes very accurately, with
sensitivity sometimes exceeding 99% [2]. As a result of
the declining cost and increasing ease of genome
sequencing in recent years, 1,699 prokaryotic genomes
(113 archaea and 1,586 bacteria) have been completely
sequenced, and nearly 5,000 more draft genomes have
been deposited in public archives. The genomes of most
of these species have been sequenced and annotated by* Correspondence: dwood@cs.umd.edu
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reproduction in any medium, provided the orrelatively large sequencing centers, but many smaller
centers and even individual laboratories have contribu-
ted some genomes as well. The continuing reduction in
the cost of sequencing suggests that the trend towards
sequencing by small laboratories will increase substan-
tially in the future. Many of these smaller laboratories
do not have substantial in-house bioinformatics expert-
ise. The annotation process can vary greatly from one
center to the next, and even within a center it varies
from year to year, with different programs used for gene
finding, alignment, and assigning gene names.
Several different gene finding programs have been
used over the years, including Glimmer [2-4], GeneMark
[5,6], and others, and each of these programs has itself
gone through different versions that produced changes
(mostly improvements) in their performance. The one
program that has been consistently used over the years
and across all species is BLAST [7], which is most com-
monly used to search predicted protein-coding genestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proteins. Significant sequence similarity with a protein
in another species is strong evidence that the predicted
protein is genuine, especially if the target species is evo-
lutionarily distant. BLAST searches for homologous
sequences have long been the gold standard of evidence
for gene prediction.
As a result of the various methodologies, annotation is
not very consistent between prokaryotic genomes, even
for different strains of the same species, unless the anno-
tation was all performed at the same sequencing center
and within a relatively short time period. Genes can be
missing from the annotation of some strains and present
in others; their start codon positions can vary widely,
yielding genes with apparently different lengths; genes
can be labeled as pseudogenes or not, depending on the
conventions used by the original annotators; and genes
can be annotated on the wrong strand or the wrong
reading frame. Other differences in annotation programs
or in the parameters used to run them can also influence
the set of genes found, for example by omitting genes
below an arbitrary length threshold. Addressing these
inconsistencies should improve current methodologies
for prokaryotic annotation.
Obtaining perfect annotation for a bacterial genome is
still beyond our reach, even though methods continue to
improve. Thus it is reasonable to assume that there are
genes missing in current annotations. Finding even some
of those genes that have been omitted and correcting
other flaws will have direct effects on our biological
understanding of the species in question. Many of the
missed genes can be associated with specific biochemical
functions, thus contributing to our knowledge of the
species’ molecular machinery. In some cases, for
example when a missed gene in a potentially pathogenic
organism is associated with antibiotic resistance, identi-
fying it can help us better understand the causes and
treatments of infections.
For this reason, we took a very broad look at all the
completely sequenced prokaryotic genomes to determine
how many likely genes are simply missing from the
annotation and are easily found with our proposed pipe-
line. We focused on this question because protein
sequence homology, as measured by BLAST, provides a
highly reliable, consistent tool for identifying missing
genes. Although gene identification is generally much
better for prokaryotes than for eukaryotes (whose gene
structure is much more complex), many genes are none-
theless missing entirely from finished, published genomes.
In this work, we do not intend to find the entire set of
missing genes but instead to demonstrate a relatively
simple way to find a large set of likely missed genes.
In addition to identifying thousands of missing genes,
we also provide some possible explanations for theiromission, and provide analysis and information about
each missed gene in a publicly available database (see
details below). It is important to note that there are add-
itional issues with gene annotation that are beyond the
scope of our work, but should be addressed by the anno-
tation community. In addition to missing genes, we
found many other inconsistencies, including genes of
varying lengths and with clearly incompatible names,
but resolving those inconsistencies is much more diffi-
cult, often involving manual curation.
Another problem that may arise in genome annotation
is the problem of overannotation, the incorrect annota-
tion of ORFs in genomes which are not true genes.
Unfortunately, there are no reliable methods for defini-
tively determining that a particular ORF is not a true
gene. Experiments can show that an ORF is not
expressed under certain conditions, but showing that an
ORF is not expressed under all conditions is not feasible.
There have been attempts to quantify overannotation by
examining the length distribution of annotated genes,
and showing that the length distribution of all annotated
genes does not match the length distribution of only
annotated genes with supporting homology to known
genes [8]. Since it is impossible to precisely determine
the extent of overannotation in a genome, we focused
on finding unannotated genes that had considerable
computational support for their protein-coding nature
and were able to be found with freely available and com-
monly used software.
Our approach to finding missed genes involves using a
combination of Glimmer to find ORFs that were likely
to be protein-coding genes, which were not present in
the existing annotations from GenBank [9], and then
using BLAST to find genes that had significant sequence
similarity to previously annotated genes. After ruling out
potential pseudogenes, we were left with 52,605 ORFs,
which we called candidate missed genes, from 1,474
completely sequenced prokaryotic genome annotations.
Although many of the candidate missed genes had
sequence similarity to proteins with functional annota-
tions, providing strong evidence that they were true
missed genes, there were also many candidate missed
genes with sequence similarity to only hypothetical pro-
teins, which are putative proteins with no known func-
tion. These hypothetical proteins may have only been
predicted by gene prediction programs without add-
itional evidence to support a claim that they are true
genes. For those candidate missed genes with homology
only to hypothetical proteins, we needed additional
information to determine if they were indeed genes.
To this end, we make use of the newly available
resource COMBREX [10], which is an online database
[11] containing functional predictions and phenotype
information for more than 3 million microbial genes
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base, we were able to assign each gene to a COMBREX
support level, which helps estimate how likely each
potential missed gene found is to be a true protein-
coding gene. For instance, if a candidate missed gene
has a homolog in COMBREX that has been experimen-
tally cloned and tested for function, we assign the gene
to the strong COMBREX support level, and our confi-
dence that this candidate missed gene is a fully func-
tional, protein-coding gene increases. In our analysis,
most of the candidate missed genes that share sequence
similarity with non-hypothetical proteins were found to
have strong COMBREX support. For the candidate
missed genes that only have sequence similarity to hypo-
thetical proteins, a significant number were also found
to have evidence from COMBREX showing that they are
likely protein-coding genes. Additionally, we were able
to use COMBREX to assign functional and phenotype
information to many of the missed genes we identified.
Previously, Warren, et al. [12] performed a similar
study to find missing genes in 1,297 annotated prokary-
otic chromosomes and plasmids in RefSeq. They
reported over 38,000 of what they termed “absent anno-
tations”, or “putative genes by similarity to currently
annotated genes” [12]. Our criteria for determining
candidate missed genes roughly match their criteria
for determining “absent annotations,” although we find
more candidate missed genes, as we analyze more
genomes. Warren, et al. also found 1,000 additional
“missed genes,” which are unannotated ORFs with se-
quence similarity to other ORFs in other distant species.
Our analysis differs from Warren, et al. by going fur-
ther to determine the subset of candidate missed genes
that have strong support to be actual protein-coding
genes, and analyzing them with COMBREX. We use
COMBREX both to provide further evidence of the
gene’s protein-coding nature, and to draw attention to
candidate missed genes with important phenotypes that
might be of special interest. We also suggest possible
reasons for the omission of missed genes, which can be
put into practice to improve future annotation efforts.
Although the analysis of Warren, et al. may find more
missed genes, as they analyze every intergenic ORF, our
focus on predicted yet unannotated genes is able to find
a comparable number of missed genes while expending
less computational effort in the task of searching for
homologous genes. We found that Glimmer predicted
over 97% of genes in RefSeq bacterial genome annota-
tions, suggesting that our approach will find a substan-
tial number of missed genes without needing to search
all intergenic ORFs. Even though a small number of
missed genes may be overlooked by our approach, our
goal with this study was not to find all missed genes, but
rather a large subset thereof that could be easily foundthrough existing tools. This large subset of missed genes,
while not complete, should nonetheless be useful for the
research community.
Currently, the entire set of missed genes is accessible
online [13] in the form of downloadable lists of genes
and sequences, divided by some basic criteria. Eventu-
ally, these genes will be fully integrated into COMBREX,
which will allow one to search for a particular gene
based on specific attributes, view information associated




The process used to identify missed genes is summarized
in Figure 1. We began by looking at a set of 1,574 pro-
karyotic chromosomes with GenBank annotations from
1,474 completely sequenced genomes. We used Glim-
mer3 [2] and a few consecutive filtering steps to identify
a set of candidate missed genes. These genes were
further separated into two distinct subsets based on the
nature of the homologs of each individual candidate
missed gene. A candidate missed gene that shared sig-
nificant sequence similarity (based on BLAST similarity
scores) with a known gene with non-hypothetical anno-
tation was termed a named missed gene. Named missed
genes are very likely to be missed genes, given their
homology to a known protein with functional annota-
tion. The remaining candidate missed genes were
termed hypothetical missed genes. These two phases of
the pipeline are described in more detail in the first part
of this Methods section.
In the next step, we mined COMBREX for functional
information about the candidate missed genes. We were
able to assign functional and phenotype information to
many of the missed genes using ComBlast, a tool that
associates the query missed genes with existing data in
COMBREX through sequence similarity methods. Based
on the data stored in COMBREX, we were also able to
assign COMBREX support levels to each missed gene,
indicating whether or not it was a true protein-coding
gene. Both COMBREX and its use in our analysis are
described later in this section.
Preprocessing and filtering
As shown in Figure 1, we first downloaded all GenBank
files (files with a .gbk extension) corresponding to pro-
karyotic genomes from NCBI [9] on May 16, 2011. We
then removed any GenBank files that represented plas-
mids so that we could focus on the main chromosomes.
We decided to exclude plasmids from our analysis
because gene prediction methods do not work well on
very small sequences, and plasmids typically represent
only a small percentage of a genome. We also removed
BLAST Database of all bacterial genes













For each genome and its
associated annotation,
these commands were run
















Figure 1 Data flow through our analysis pipeline. Annotations and sequences were obtained from GenBank, and all sequences were
processed with the Glimmer 3 gene finder to obtain gene predictions. Sets of predicted genes were filtered to exclude annotated genes and
pseudogenes to obtain a set of candidate missed genes. These predicted genes were input as queries to BLAST against a database of all bacterial
genes in RefSeq. Predicted genes were then designated as named missed genes or hypothetical missed genes, based on if they had a significant
alignment to a non-hypothetical protein, or only aligned to hypothetical proteins, respectively. Each of these two sets were further analyzed by
ComBlast, which uses BLAST and the COMBREX database to associate genes with additional attributes, such as experimentally determined
function, 3D structure, conservation and phenotype information and assign a COMBREX support level to each potential missed gene.
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at all, presumably because the annotations have not yet
been completed. This was an important filtering step as
it eliminated around 100,000 of the missing genes we
originally thought we found.
Similarly, we took care to remove any draft genomes,
as Glimmer may make gene predictions which extend
beyond the end of a contig or extend into a region con-
taining many ambiguous nucleotides in the sequence.
Since we were unsure if the new genes we found for
these genomes were true missed genes, we decided
instead to exclude draft and incomplete sequences that
we had initially found in the list of “complete” genomes
at NCBI. We excluded 36 genomes containing the
phrases “draft” or “nearly complete” in the header line, or
whose sequences contain more than 10 distinct locations
with at least 5 consecutive ambiguous nucleotides. After
performing these initial filtering steps, we were left with
1,574 GenBank files, for which we used Glimmer3 and
BLAST to find our final set of candidate missed genes.
Gene prediction and finding missed genes
For each of the 1,574 chromosomes, we generated a set
of ab initio gene predictions by running Glimmer3 withthe g3-iterated.csh script, yielding roughly 4.94 million
predicted genes. The only modifications we made to the
standard options in the g3-iterated.csh script were for
35 chromosomes, mostly from the genus Mycoplasma,
that use a non-standard genetic code, where we ran
Glimmer3 with the option "-z 4" to set the stop codons
used by Glimmer3 to be only TAG and TAA.
We then compared the predicted genes with the anno-
tations in the original GenBank file to find roughly
350,000 predicted genes missed in the GenBank annota-
tion. A predicted gene was considered present in the
original annotation if its 3' end was shared with any
annotated CDS in the GenBank file. Predicted genes
were also eliminated if they overlapped other annotated
features, such as RNAs, gene features without a CDS,
and CDS entries with a '/pseudo’ tag, by more than 50%.
For the roughly 350,000 gene predictions that
remained, to determine which of these might be true
missed genes, we created a BLAST database containing
all proteins from every bacterial genome listed in the
RefSeq database [14], which was approximately 4.2 mil-
lion proteins as of March 28, 2011. We then translated
and aligned each of the remaining predicted genes
against this protein database.
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many useful results, some of the false predicted genes
may also have a low-scoring alignment that, absent any
further processing, would lead us to call this false gene
a missed gene. Therefore, to ensure that the pairs of
homologous genes implied by these BLAST alignments
were indicative of true pairs (as opposed to alignments
that could occur simply by random chance), we used
three filters: an E-value threshold of 10-6, an alignment
coverage requirement, and the requirement that the
alignment was to a gene with assigned function. We
discuss each in more detail below.
The E-value of an alignment A is the expected number
of alignments of the query that would score as well as A
by random chance alone, and is dependent on the length
of the query and the size of the database searched
against [15]. The probability of finding an alignment that
scores as well as A (the P-value) is related to the E-value
by the equation P = 1 - exp(−E) [7]. For the E-value 10-6,
the P-value is also 10-6, which means the expected num-
ber of our 350,000 predicted genes that would align to
the database of proteins by chance alone should be less
than 1, according to the model used to calculate BLAST
E-values. Of the 127,000 possible missed genes that had
a BLAST alignment, only 78,000 had an alignment that
passed through this filter.
However, many of the proteins in our database are
homologous to many others, and so the database is not
made of independent sequences. It is unclear as to what
degree this would affect the expected number of false
homologous pairs. For this reason, as well as the pres-
ence of pseudogenes, we further filter our set of align-
ments by requiring each alignment to cover at least 80%
of the subject gene. This filter reduced our set of
possible missed genes to a total of 52,605 candidate
missed genes.
Finally, even if a predicted gene were an exact amino
acid match to a gene in RefSeq, there is the possibility
that the RefSeq gene is simply an incorrect computa-
tional prediction. The RefSeq database has many hypo-
thetical proteins, and it is likely that a significant
fraction of such genes are not true genes. Those genes
that have an assigned function have such an assignment
due to either an experiment verifying that function or
high sequence similarity to an experimentally-confirmed
gene. This means that those genes with assigned func-
tion should have a higher probability of being true genes
than those without.
Therefore, we divide our remaining candidate missed
genes into two groups: those with sequence similarity
to a protein without the string “hypothetical” in its
description (or any of several common spellings of
hypothetical), designated named missed genes; and those
with sequence similarity only to hypothetical proteins,which we designated hypothetical missed genes. Our
analysis yielded 13,602 named missed genes and 39,003
hypothetical missed genes that we further analyzed
using COMBREX.
COMBREX
COMBREX (Computational Bridges to Experiments) is
an NIH funded effort to bring computational and experi-
mental biologists together. It serves as a clearinghouse
for computationally determined gene function predic-
tions, prioritizes these for experimental testing, and
offers grants to experimental biologists to test specific
predictions [10]. COMBREX maintains a database [11]
of experimentally determined and computationally pre-
dicted functions for more than 3 million microbial
genes. The genes in the COMBREX database are orga-
nized into functionally linked gene groups. In the default
scheme, the genes are grouped into sequence-similar
and likely isofunctional groups, as defined by the NCBI
Protein Clusters Database [16].
COMBREX is the first functional database that
attempts to provide fully traceable annotation, where pre-
dictions are traced (whenever possible) to the experimen-
tally determined evidence. For many genes COMBREX
provides a link to the nearest gene with experimentally
determined function, as determined by both BLAST simi-
larity score and shared domain composition.
In addition, COMBREX also provides information
about documented phenotypes associated with each
gene. Currently, this phenotype data consists of anti-
biotic resistance, antibiotic sensitivity, and candidate
gene essentiality. Antibiotic resistance genes, obtained
from Antibiotic Resistance Genes Database [17], confer
resistance to one or more antibiotics through several
mechanisms. Antibiotic sensitivity genes are genes that
when lost, confer increased sensitivity to antibiotics [18].
The essential genes are identified, by multiple sources,
as being essential for growth or viability in one or more
organisms (a complete list of the organisms and sources
can be found at the COMBREX web server).
COMBREX analysis
Approximately 75% of the total missed gene set is com-
prised of hypothetical missed genes, for which the anno-
tation of related proteins in GenBank provides no useful
functional information. However, we were able to pro-
vide additional information for many of these hypothet-
ical missed genes with COMBREX, by utilizing the
ComBlast annotation pipeline, which we describe below.
Based on the data stored in COMBREX, ComBlast
associates each missed gene with various types of
important evidence or data. Consider a case of a hypo-
thetical gene prediction identified in two closely related
strains using the same gene prediction software. Clearly,
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a roughly similar k-mer distribution in the predicted
region. Our confidence in the prediction grows if the
same prediction is found in a large number of organisms
suggesting this gene is conserved. The confidence also
grows if one of the homologs has been explored experi-
mentally. This principle is deployed systematically
throughout our study. The evidence associated with each
gene includes any one of the following attributes: con-
servation of the gene, evidence of experimentally vali-
dated function or predicted molecular function, existing
3D structures or protein domains, protein purification
status, EC numbers, and gene phenotype. A missed gene
is associated with specific evidence if it shares significant
sequence similarity with individual genes with this type
of information, or if it is assigned to one or more protein
clusters in COMBREX (with at least one gene in the
cluster having the required information). For the pur-
pose of this paper, missed gene A shares significant
sequence similarity with COMBREX gene B if the se-
quence alignment of A against B covers at least 80% of
the length of B and has BLAST E-value less than 10-5.
If gene B contains any of the above mentioned evidence,
they are assigned to gene A. Gene A can also be
assigned to protein cluster C if A shares significant
sequence similarity with at least 100 members in that
cluster (for big clusters) or all members in the cluster
(for smaller clusters), or if A shares significant sequence
similarity with members of only one cluster.
The information from COMBREX is used to assign
each missed gene to a COMBREX support level. A
missed gene is assigned to the strong COMBREX sup-
port level for being a true functional gene if the gene is
found to be conserved in multiple organisms. We define
a gene as conserved in multiple organisms if it is
assigned to a cluster with more than 50 members com-
ing from at least 2 different phyla or if it shares signifi-
cant sequence similarity to more than 50 COMBREX
genes. Additionally, a missed gene is assigned to the
strong COMBREX support level if it has significant simi-
larity to one or more genes associated with at least one
of the following types of information: experimentally vali-
dated function with evidence, known 3D structure, pres-
ence of purified protein, protein domain, or EC number.
A missed gene not assigned to the strong support level
is assigned to the fair COMBREX support level if it sat-
isfies one or more of the following conditions: if it is
assigned to at least one cluster having a computational
prediction for its genes, if it is assigned to at least one
cluster containing 5 or more members, or if it shares
significant sequence similarity to 10–50 COMBREX
genes. The remainder of the named missed genes that
do not match the strong or fair criteria, are assigned the
weak COMBREX support level, since they still havesignificant sequence similarity to genes with meaningful
functional annotation. Other hypothetical missed genes
that do not match the strong or fair criteria are labeled
as having the insufficient COMBREX support level.
Spurious gene family analysis
Along with our use of ComBlast to examine the support
available for our candidate missed genes, we used Anti-
Fam [19] to examine our candidate missed genes to deter-
mine if there is any evidence that they are not true genes.
AntiFam is a database of hidden Markov models (HMMs)
that represent families of genes that have been incorrectly
annotated in the past frequently. In this study, we use
AntiFam 2.0, which contains 47 HMMs representing fam-
ilies that include genes from ORFs that overlap known
rRNAs, tRNAs, and other genomic features.
Results and discussion
ComBlast results
By the end of our search for candidate missed genes,
we found 13,602 named missed genes with significant se-
quence similarity to a known gene with non-hypothetical
annotation, and 39,003 hypothetical missed genes with
homology only to hypothetical proteins. 13,307 of the
named missed genes and 36,127 of the hypothetical missed
genes had significant sequence similarity to COMBREX
genes, and could be further analyzed using COMBREX.
We started by using COMBREX to assign a confidence
level to the 13,602 named missed genes. Using ComBlast,
the annotation pipeline in COMBREX, we assigned 63%
of the named missed genes to the strong COMBREX
support level and 18% to the fair level (Figure 2). In
addition, while taking into account the hypothetical
missed genes, we were able to double the number of
likely genes that have at least the fair COMBREX sup-
port level for being protein-coding genes. In total, we
can assign the fair COMBREX support level to another
11,792 genes from the hypothetical missed gene set,
which illustrates the limitations associated with sequence
homology based prediction methods (Figure 2). 2,824 of
the hypothetical missed genes are assigned to the strong
COMBREX support level (for examples see Table 1), and
more than 3,000 genes also have some information
through functional predictions of other genes.
We also used COMBREX phenotype data to identify
potentially important (scientifically or clinically) missed
genes. We could associate 1,264 missed genes with
phenotype data stored uniquely in COMBREX (Figure 3A
and Table 2). Even genes that could not be associated
with any meaningful functional evidence through BLAST-
based analysis have been shown to contain interest-
ing phenotype information; we found 46 such cases (see
example 3 in the last column of Table 2). In our set
of missed genes, we were able to find candidates that
Figure 2 Assignment of COMBREX support levels to the hypothetical/named missed genes using ComBlast. For each missed gene we
assign a COMBREX support level based on sequence homology and assignment to gene clusters in COMBREX. A missed gene has the strong
COMBREX support level of being a true protein coding gene if it is conserved or associated with at least one of the following information:
possessing experimentally validated function, known 3D structure, purified protein, protein domain or EC number. It has the fair COMBREX
support level if it has a sufficient number of homologs or is associated with a predicted function. The other named missed genes, which were
confirmed by sequence homology to at least one gene with non hypothetical protein annotation, have a weak COMBREX support level. The rest
of the hypothetical genes have insufficient evidence and thus they are not counted in the statistics of missed genes in this paper. See the text
for more detailed description of the different levels.
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associated with antibiotic resistance, 210 with antibiotic
sensitivity, 852 with candidate essential genes and an
additional 176 genes that could be associated both with
candidate essential genes and antibiotic sensitivity.
Along with providing functional and phenotype related
information to the missed genes, COMBREX also tries
to identify which of these genes might be medically rele-
vant. These genes may be potential drug targets in the
future. To identify such cases, we considered 3 different
criteria that the missed genes have to satisfy: (i) the
missed gene should belong to a pathogenic organism
(according to The Microbial Rosetta Stone Database of
Pathogens [20]); (ii) the missed gene should be assigned
to a protein cluster with at least 50 members (based
on ComBlast results); and (iii) the missed gene should
possess significant sequence similarity to any essential
gene within COMBREX (based on ComBlast results). By
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gene was ide88 different pathogenic organisms, that satisfied all the
above criteria and thus might be interesting drug targets
(Figure 3B). The full list of those genes is also available
online [13].
Spurious gene family analysis
To identify spurious genes in our set of candidate missed
genes, the AntiFam database of HMMs was compared
against both our named missed genes and hypothetical
missed genes. 8 of the 13614 (0.06%) named missed
genes, and 141 of the 39003 (0.36%) hypothetical missed
genes were labeled as spurious according to AntiFam.
We also show the number of spurious missed genes as
divided by COMBREX support level in Table 3.
The low number of genes in our named missed genes
set that were labeled spurious is encouraging, as we had
hoped demanding a functional assignment would result
in few false positives. As may be expected, the percent-
age of genes in the hypothetical missed genes set thatciated with the strong COMBREX support level
association with the strong support level
the NCBI curated cluster PRK11770. The ORF has 213 significant
mologs (BLAST E-values range between 1e-58 to 3e-09) in the cluster.
ontains 218 genes from 125 species belonging to 6 different phyla. It has
domain along with a few cloned and purified members.
the NCBI cluster CLSK496073. All other members of the cluster are
proteins (NCBI annotation), but COMBREX identified 3 experimentally
es within the cluster.
t sequence similarity (BLAST E-Value 1e-09) to a gene from Aeromonas
at is included in the gold-standard database in COMBREX (a novel set of
xperimentally validated molecular function).
t sequence similarity (BLAST E-Value 2e-21) to a protein from Sulfolobus
ith NCBI annotation as hypothetical protein. However, in COMBREX this
ntified as having a known 3D structure (PDB code: 2JTM).
Figure 3 Missed genes that can be associated with COMBREX phenotype data: (A) Phenotype data distribution. Some of the missed
genes can be associated with phenotype data using the novel COMBREX resource. A gene is associated with a specific phenotype if it has
significant sequence similarity (see Methods) to a gene in COMBREX with the phenotype or if it is assigned to a cluster containing a gene with
the phenotype. (B) Potential drug target genes (see text for details) with their distribution in pathogenic organisms (identified only to the species
level). The largest portion of these genes belongs to the Enterobacteriaceae family of pathogens (Yersinia, E. coli, etc.) as seen in the figure.
This phenotype information is pooled together using ComBlast. The full list of these genes is available online [13].
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due to the lack of a functional assignment in the hom-
ologous genes used to add genes to the hypothetical set.
Five of the spurious genes (all belonging to Haemophilus
influenzae F3031) appeared in our named missed genes set
due to a single gene annotated in the RefSeq annotation of
H. influenzae F3031 (HIBPF15861, described as “cell wall-
associated hydrolase”) that AntiFam indicates is from a re-
gion that is antisense to 23S rRNA; a sixth spurious gene
was due to a homologous annotated gene in Lactobacillus
crispatus ST1. The other two spurious genes in this set,
called translations of CRISPR regions by AntiFam, are
homologs to two genes in Syntrophus aciditrophicus SB
that were annotated as a “putative cytoplasmic protein” at
the time we obtained our set of annotated genes in RefSeq,
but now are no longer in the RefSeq record.
We also examined the 51 hypothetical missed genes
that were assigned to the strong COMBREX support
level, yet were labeled as spurious by AntiFam. One
of these genes was a translation of a tRNA, one was
contained within a repeat in the Vibrio superintegron,
and six were contained within the insertion sequence
ISlin1. The remaining 43 were labeled as translations of
CRISPR regions, with 41 of those being part of a family
described by a single HMM. Analysis of these 41 genesTable 2 Examples of missed genes associated with COMBREX
Assigned Name CP001172_orf00556
Species containing missed gene Acinetobacter baumannii AB307-0
Species containing homologous gene Escherichia coli ED1a
Name of homologous gene dimethyladenosine transferase
Blast E-value 9e-75
Combrex phenotype associations antibiotic resistance class KsgA
Three representative examples of missed genes that are associated with COMBREX
essential gene”. Note that CP002071_orf01199 is a hypothetical missed gene with Brevealed that their entry into our candidate missed genes
set was, in all but 3 cases, due to homologous genes that
existed in RefSeq at the time we generated the set but
that are no longer in the RefSeq database. In addition,
all 46 of the spurious hypothetical missed genes assigned
to the fair COMBREX support level were translations of
antisense rRNA regions.
In summary, many of the spurious genes that we
found in our set of candidate missed genes appear to
have been introduced into our set by the existence of
genes in a slightly outdated version of RefSeq (that have
since been removed). There are also many spurious
genes that overlapped rRNAs, indicating that the ori-
ginal annotators missed rRNA genes, as our pipeline
excluded ORFs that overlapped annotated rRNAs. These
two large groups of spurious missed genes, although less
than one percent of our total set of missed genes, indi-
cate two other problems with existing annotations that
do not involve missing protein-coding genes.
Missed genes analysis
In addition to finding missed genes, we conducted fur-
ther analysis looking for patterns in the data that might
explain why these genes were missed. Note that our ana-
lysis here is limited to the genes found via our pipeline,phenotype data
CP000948_orf05287 CP002071_orf01199
294 Escherichia coli K-12 substr. DH10B Helicobacter pylori Sat464
Escherichia coli K-12 substr. MG1655 Helicobacter pylori 26695
adenylate cyclase (EC 4.6.1.1) hypothetical protein
0.0 1e-176
picin sensitivity and triclosan sensitivity candidate essential gene
phenotype data: “antibiotic resistance”, “antibiotic sensitivity”, or “candidate
LAST similarity only to hypothetical proteins.
Table 3 Spurious genes found within the various subsets







Strong 8/8581 (0.09%) 51/2824 (1.81%)
Fair 0/2498 (0%) 46/8968 (0.51%)
Weak 0/2228 (0%) 0/0 (0%)
Insufficient 0/0 (0%) 44/24437 (0.18%)
Totals 8/13307 (0.06%) 141/36127 (0.39%)
The number of spurious genes and number of total genes within each
combination of COMBREX support level (strong, fair, weak, and insufficient)
and missed gene category (named and hypothetical) is given, as found by
running candidate missed genes against the AntiFam database. This table
includes only the candidate missed genes that could be analyzed by
ComBlast.
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analyzing the missed genes we found.
We first checked if the center performing the annota-
tion influenced the number of missed genes in each an-
notation. The majority of gene annotations were done
by 4 major organizations: the Department of Energy
Joint Genome Institute (JGI), The Institute for Genomic
Research (TIGR), the J. Craig Venter Institute (JCVI),
and the Sanger Institute. These four institutes were
responsible for over half of all the annotations that we
reviewed in this study. The other centers that provided
genome annotations were typically smaller and only did
a few genome annotations each.
In analyzing the number of missed genes by each cen-
ter, we focused solely on analyzing the number of named
missed genes, as we had good confidence that most of
the named missed genes were true missed genes. When
comparing the number of named missed genes from
each of the four major centers with the number of
named missed genes from the other smaller centers, we
found that a higher relative proportion of named missed
genes came from smaller centers, suggesting that a lack
of adequate resources or experience may have contribu-
ted to the higher error rate. Reasons for missing genes
might also include using a less sensitive gene finder or
gene annotation pipeline.
Overall, for the four major institutes, we found be-
tween 0.71 to 3.92 named missed genes for each Mbp
of sequence annotated, while for the other smaller
centers, the average number of named missed genes
found per Mbp was 4.48. We also computed the per-
cent of named missed genes found versus the number
of originally annotated genes. Here we found that the
four major institutes missed between 0.08% and 0.43%
of the genes, while the other centers missed on aver-
age 0.48% of the genes. The exact numbers of named
missed genes for each of the major centers compared
to other centers are provided in Table 4 along with
some other statistics.To examine the distribution of missed genes further,
we divided the 1,574 annotations into two groups, with
one group containing annotations from the four major
centers, and the other group containing all other annota-
tions; each group was then ranked by the number of
missed genes per Mbp. By plotting each annotation’s
rank within its group against the annotation’s number of
missed genes per Mbp (Additional file 1: Figure S1), a
clear visual distinction between the two groups is evi-
dent. A more detailed examination of those annotations
with at least 10 missed genes per Mbp reveals that of
the 97 such annotations, 79 (81%) were performed by
centers other than the four major institutes. Although
the major centers do have some annotations that are
missing many genes, and some smaller centers miss
none or very few genes, clearly the general trend is that
the major centers miss fewer genes than the smaller cen-
ters. This trend is further confirmed when we examine
the relationship between the missed gene rate of a center
and the number of annotations the center has performed
(Additional file 1: Figure S2), as well as view the distri-
bution of missed gene rates on a per-chromosome basis
within the sets of annotations performed by a particular
center (Figure 4).
Another observation from our analysis of the set of
named missed genes is that many of them are short
genes, under 300 bp in length. Examining the shortest
annotated gene for each chromosome reveals that some
of the annotators likely used a minimum gene length
higher than the 110 bp cutoff we used, which may
account for some of these short genes being missed. In
fact, for the annotations of two strains of Yersinia pestis,
Z176003 and D182038, all 200+ missed genes were
under 300 bp, while the minimum annotated gene
length in the original annotations was 300 bp. In these
cases, it is clear that the minimum gene length setting
was the primary cause of these genes being missed.
In our analysis, we used a minimum gene length of
110 bp when running Glimmer3 to find missed genes.
This minimum length was used as it is the default length
supplied by Glimmer3’s g3-iterated.csh script. It appears
that based on the smallest annotated gene in each
chromosome, some annotators use a higher minimum
than 110 bp, which may result in missing shorter genes.
Although short genes were not the sole cause of missed
genes, we found that about 60% of the named missed
genes were genes of length between 110 bp and 300 bp.
A full histogram of the lengths of the missed genes we
found is shown in Figure 5, and we can see that many of
the genes have length less than 300 bp.
In addition to checking the distribution of gene
lengths, we also checked to see if the annotations with
the highest missed genes were all from several years ago,
or if there were still high numbers of genes being missed
Table 4 Results of named missed genes analysis
Center JGI TIGR JCVI Sanger Others Total
Chromosomes annotated 563 95 68 67 781 1574
Named missed genes 1463 852 190 892 10205 13602
Annotated genes 1830805 254484 179284 205667 2105188 4575428
Average named missed genes per chromosome 2.60 8.97 2.79 13.31 13.07 8.64
Percent named missed genes vs. annotated genes 0.08% 0.33% 0.11% 0.43% 0.48% 0.30%
Total chromosome length (Mbp) 2058.6 273.9 190.1 227.7 2276.6 5026.9
Named missed genes per Mbp 0.71 3.11 1.00 3.92 4.48 2.71
The statistics here only count named missed genes and do not include hypothetical missed genes, as the lack of an association with a known function makes it
more difficult to determine if a potential gene is a true gene.
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certain when each annotation was done, as many anno-
tations did not have publications associated with them,
and for the ones with publications, there was still some
chance that the annotation was done many years before
the publication. However, we did find a number of
missed genes in annotations associated with publications
from the past five years. There was one particular
example where the annotation of Lactobacillus fermen-
tum CECT 5716 (accession CP002033) was described in
a 2010 publication [21], yet the annotation still had over
100 missing genes per Mbp. This example had only 29
out of 224 missed genes under 300 bp in length, indicat-
ing that recent gene annotations may still miss manyFigure 4 Missed gene rate distributions per center. For each of
the four major centers, as well as the other centers as a group, a
representation of the distribution of the missed gene rates for the
centers is shown. For an individual center, all chromosomes
annotated by that center had their missed gene rates calculated,
and the 80th and 95th percentiles are displayed along with the
minimum and maximum missed gene rates.genes that are not short. One last factor we checked was
to see if the missed gene rate of an annotation was influ-
enced by the GC content of the genome, but we did not
see any noticeable correlations (data not shown).
We further examined the ten genomes that had the
highest named missed gene rates; these genomes are
listed in Table 5. Of these ten, 8 were annotated by smal-
ler centers, with only one annotated by JGI (Bacillus
thurengiensis) and one by the Sanger Institute (Strepto-
coccus pneumoniae). The presence of E. coli, Y. pestis,
and B. thurengiensis genomes on this list is especially
surprising, given the high number of closely-related gen-
omes that have been sequenced and annotated, which
should have made annotating these genomes easier.
We were able to find information regarding the gene
finding programs used for 7 of these ten annotations; the
annotations for Neisseria gonorrhoeae [22], L. fermentum
[21], and S. pneumoniae [23] lacked an accompanying
publication detailing the annotation methods. Glimmer
version 3 was used in the annotation of the three Y. pestis
genomes [24] in Table 5. Three other annotations (Sodalis
glossinidius, Clostridium tetani, and B. thurengiensis) used
Glimmer version 2 as part of their annotation [25-27]. In
addition, GenomeGambler 1.51 [28] was used to find
genes in the annotation for S. glossinidius [25], although it
is unclear how the results from GenomeGambler and
Glimmer were combined. The annotation of E. coli used
the GeneQuest program sold by DNASTAR for finding
genes [29]. Looking at the shortest annotated gene in
these ten annotations reveals the likely use of a high mini-
mum gene length in the process of annotation. Five anno-
tations have no genes less than 240 bp in length, and in
each of these five annotations, the majority of missed
genes were less than 300 bp in length. This appears to in-
dicate that in these cases, the use of a high minimum gene
length was the primary cause of these annotations’ high
missed gene rates.
In the remaining five cases, the cause of the high rates
of missed genes is less clear, largely due to a lack of
information about the annotation methods used. For only
two of these remaining genomes do we have a description
Figure 5 A histogram of the lengths of 13,602 named missed genes found in 1,574 prokaryotic chromosomes. Of the 13,602 named
missed genes found in our study, 7,627 were less than 300 bp in length, indicating a strong tendency on the part of some annotators to omit
shorter genes from genome annotation.
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for S. glossinidius, two gene finders’ results were used in
an ambiguous manner.
We also wanted to determine if the genes missing
from the 10 GenBank annotations listed in Table 5 were
also missing from their corresponding RefSeq annota-
tions. Although RefSeq does contain manually curated
genomes for some organisms, many annotations for bac-
terial genomes are listed as “provisional”, meaning that
they have not yet undergone final review by NCBI staff.
As many RefSeq annotations for prokaryotic genomes
are largely based on the genomes’ GenBank annotations
when provided [14], the RefSeq annotations may still be
missing large numbers of genes. Our comparison be-
tween the two sets of 10 annotations, detailed in Table 6,
revealed that only 13 genes were unique to RefSeqTable 5 The ten chromosomes with the highest named misse




N. gonorrhoeae FA 1090 AE004969 2.15 107.7
L. fermentum CECT 5716 CP002033 2.10 106.6
S. glossinidius str. ‘morsitans’ AP008232 4.17 89.7
E. coli APEC 01 CP000468 5.08 62.0
C. tetani E88 AE015927 2.80 55.7
B. thurengiensis str. Al Hakam CP000485 5.26 52.9
S. pneumoniae INV104 FQ312030 2.14 52.3
Y. pestis Z176003 CP001593 4.55 50.9
Y. pestis D106004 CP001585 4.64 50.9
Y. pestis D182038 CP001589 4.63 50.8annotations, while 43 genes were unique to GenBank
annotations. Of the 13 genes unique to RefSeq annota-
tions, 11 were in our set of named missed genes.Conclusions
In this study, we found and made publicly available a
substantial number of genes missed in the annotations
of prokaryotic genomes in GenBank. Through analysis
on 1,474 completely sequenced prokaryotic genomes, we
found 13,602 genes missed that had significant amino
acid sequence similarity to named (non-hypothetical)
genes in NCBI’s RefSeq database. We also found 39,003
missed genes which had significant sequence similarity
only to genes annotated as hypothetical protein, and



















Table 6 Comparison of GenBank and RefSeq annotations for the ten chromosomes with the highest named missed
gene rates
Genome GenBank annotation RefSeq annotation Common genes
# Genes # Unique Genes # Genes # Unique Genes # Genes # 50 changes
N. gonorrhoeae FA 1090 2002 0 2002 0 2002 9
L. fermentum CECT 5716 1051 0 1051 0 1051 0
S. glossinidius str. ‘morsitans’ 2432 0 2432 0 2432 13
E. coli APEC 01 4467 39 4430 2 4428 72
C. tetani E88 2373 0 2380 7 2373 21
B. thurengiensis str. Al Hakam 4736 0 4736 0 4736 33
S. pneumoniae INV104 1824 4 1820 0 1820 0
Y. pestis Z176003 3542 0 3546 4 3542 0
Y. pestis D106004 3629 0 3629 0 3629 0
Y. pestis D182038 3620 0 3620 0 3620 0
Genes not contained in both annotations (as determined by stop codon position) for a given genome are considered “unique”, while those contained in both are
“common”. For common genes, “# 5’ changes” indicates the number of genes that have differing start codon annotations.
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that they are genuine missed genes. The fact that many
of the hypothetical genes can be associated with evi-
dence from known genes highlights the need for taking
into account more information than just the gene de-
scription as is commonly done by many who use only
BLAST. COMBREX addresses this need by providing a
wider variety of information coming from many different
sources. Given the large number of probable missed
genes found by our method, we recommend it as an
addition to bacterial annotation pipelines. Although we
used Glimmer, we note other high-sensitivity gene fin-
ders, or combination of such gene finders, may also be
suitable for improving gene annotations.
We found the major centers responsible for genome
annotation generally had very few missed genes, and
their annotations missed fewer genes on average than
annotations from smaller centers. Although some smal-
ler centers did consistently produce gene annotations
with low numbers of missed genes, we found that the
majority of gene annotations with a high rate of missed
genes were from the smaller centers, which may have
less experience in gene annotation.
We also found many short missed genes, suggesting
that annotators selected a minimum gene length consid-
erably higher than Glimmer’s default of 110 bp. Use of
such a high minimum length is the likely reason behind
the lack of annotation of a large fraction of the missed
genes we found. Besides the common problem of miss-
ing short genes, it was difficult to determine the reasons
for missing the longer genes, as the methods of annota-
tion were not always detailed in GenBank or in the
annotations’ associated publications. A survey of the
genomes that had the 10 highest rates of missed genes
showed a variety of annotation pipelines and software,
indicating that there are several different approaches toannotation. As these approaches almost certainly differ
in terms of sensitivity, those seeking to perform annota-
tion should take care to ascertain the quality of their
chosen methods.
We were also able to identify several genomes without
any annotations present, and draft genomes, which
appeared on a list of complete genomes on the NCBI
Entrez Genome Project website. The presence of such
genomes on a list purported to contain “complete gen-
omes” should serve as a reminder to researchers that the
data in our public archives is not always 100% accurate.
These inconsistencies in genome annotation along with
the large number of missed genes found strongly sug-
gests the need for a common standard of best practices
to be followed by gene annotation centers, and we hope
this work can steer the attention of the annotation com-
munity towards this direction.
In addition to identifying many missed genes, we used
COMBREX to assign phenotype information to many
genes. In our phenotype analysis, we were able associate
some of the missed genes with one or more phenotypes,
such as antibiotic resistance, antibiotic sensitivity, and
essentiality. Some of these missed genes, which are con-
served in many organisms and found in potentially
pathogenic organisms, could be interesting targets for
the pharmaceutical community.
The cost of sequencing is decreasing at a very
rapid rate suggesting that the number of organisms
or clinically important strains sequenced by small la-
boratories without bioinformatics expertise will in-
crease dramatically. Our results suggest a need for
open access and high accuracy annotation software
available to the community that combines the
strengths of gene prediction programs, such as Glim-
mer, with information from protein databases, such
as COMBREX.
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Additional file 1: Figures S1 and Figure S2. Plots of prokaryotic
annotations organized by rate of missed genes; and relationship between
the named missed gene rate of a center and the number of annotations
performed.
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Reviewers’ comments
Reviewer 1: Dr. Daniel Haft
Wood and coauthors describe a study that seems to have two separate and
complementary purposes – to showcase how standardizing on GLIMMER3
used with properly set parameters might improve gene finding for
prokaryotes, and to showcase how BLAST searching vs. the COMBREX
database of genes with experimental evidence allows better verification of
coding region predictions than searching unfiltered databases. Unfortunately,
each purpose is somewhat compromised by bundling the two tasks without
benchmarking each phase of the project independently.
Because GLIMMER3 relies on analyses of k-mer frequencies in trusted sets of
coding regions from a single genome, it models what is typical across a
single genome. Consequently, islands present in that genome because of
lateral gene transfer (LGT) are handled much more poorly than the rest of
the genome. If the point is to find large numbers of genes that may have
been missed, in a computationally efficient manner, where those candidates
are slated to be filtered through a subsequent validation process anyway,
then that the pipeline probably should use GLIMMER3 and MetaGene in
combination, taking the union, and the pipeline should not filter out plasmid
replicons (an area of relative weakness for GLIMMER3, which needs a large
replicon to generate good statistical models).
It would be good to know from this study how severe the issue of missed
genes in public databases actually is. In fact, the average number of genes
picked up per archival genome submission to GenBank is small in this paper,
on the order of 10 new genes for each 4000-gene genome, suggesting
accuracy has actually been very good all along, other than the conspicuous
exceptions noted in the paper. A previous study looked at every intergenic
ORF, and found similar numbers, but that study would not have seen genes
overshadowed by spurious genes and spurious extensions to genes. The real
problem of missed genes may run closer to 3 % (by count, not by length,
since missed genes tend to be small). The current paper uses GLIMMER3 as
the only gene-finding method, and to a large extent finds genes missed by
GLIMMER in earlier incarnations or run with inappropriate parameters. I
recommend that the ab initio gene-finding phase of this study be redone,
using the union of GLIMMER and MetaGene predictions instead of GLIMMER
only (after which I would amend my remarks here).
Authors’ response: The use of multiple gene-finding programs, and taking the
union of their results, would certainly be a worthwhile step were one seeking to
build a full annotation pipeline, or even to find as many missed genes as
possible; as we stated in our introduction, however, this is not what we
intended with this study. We sought to provide a simple pipeline that would
quantify the number of new missed genes that could be found using just a few
freely available tools and resources (Glimmer3, BLAST, and RefSeq). With few
exceptions, genes found by such a pipeline should simply not be missing from
existing annotations, and if they are absent from the annotation, a reason for
doing so should be present in the annotation itself (e.g., the annotators believe
such genes to be pseudogenes). Although there are almost certainly genes that
we did not find as part of this study, we believed that by focusing attention on
these unannotated genes and the reasons for their absence, we can bringattention to the many various methods of annotation currently in use and the
need for standardization.
While we agree with the reviewer that average sensitivity appears to be quite
high, the “conspicuous exceptions” we noted are quite important, and a large
part of what we aimed to highlight with this study. The lack of review given to
GenBank submissions is not necessarily well-understood by the entire genomics
community, and as we mention later in reply to the reviewer’s point about
RefSeq, errors and omissions from a GenBank annotation can often be
propagated into the respective RefSeq annotation. Bringing these errors in the
public genomic records to the community’s attention is one of the main goals
of our paper.
The second phase of the study attempts to demonstrate how validating
predicted gene calls is improved by use of a BLAST-searchable database of
proteins in which direct experimental evidence is distinguished from
transitive evidence of function, and both are distinguished from sequences
with no evidence of representing real genes. While it is natural to pair this
part of the study with the data stream of predicted missed gene calls from
the ab initio work with GLIMMER, it is regrettable that there is no
benchmarking of the COMBLAST pipeline and COMBREX data set using
more typical data than the less-than-1-percent of atypical genes found in
phase 1. How does COMBREX do with the complete genome of an
endosymbiont such as Blochmannia floridanus? How does it do with a large,
GC-rich genome such as Mycobacterium smegmatis? The paper does not
describe proteomics as a source of evidence for confirmation in COMBREX
that a gene is translated into protein, so perhaps the best test is a set of
proteomics-verified polypeptides from, say, Yersinia.
It is difficult for the reader/reviewer to evaluate whether or not there may be
a problem in COMBREX – that some of the evidence in COMBREX may point
precisely to a genomic region and yet not necessarily indicate the correct
reading frame for that gene. Experiments based on antisense RNA, or
transposon mutagenesis, do not point to a specific reading frame. The test I
recommend is to select some GC-rich genome, make a test set by GLIMMER
ab initio gene predictions, make a negative control set from all the longest
ORFs that GLIMMER rejected from the genome, run both sets through the
COMBLAST pipeline, and compare those results.
Authors’ response: The types of analysis suggested by the reviewer are worth
doing in order to evaluate the advantages of using the newly available
ComBlast tool and the COMBREX database. However, this was not the focus of
our work. Currently we do not consider ComBlast as a tool for discovering
missed genes. However, in the context of this work, COMBREX becomes a useful
resource as it provides fully traceable annotation (whenever possible) to the
experimentally determined evidence. As such we use it to provide sources of
evidence for some of the missed genes, which we hope will help to focus the
attention of the community on that topic. We demonstrated here a simple yet
important use of that type of information, which we believe should be an
integral part of any annotation pipeline. It is important to make clear that we
do not intend to classify the missed genes as true and false positives based only
on COMBREX, since there might be many missed genes that are indeed protein-
coding genes that COMBREX cannot currently associate with any experimental
evidence. In this study we also used COMBREX to identify biologically interesting
potential genes, which others might want to further investigate. In the future,
we do plan to continue developing the abilities of ComBlast and publish a
more complete study evaluating its capabilities. We hope such a study will
provide some answers to the important questions pointed out by the reviewer.
Here are a number of additional points about the paper.
One mechanism to evaluate COMBREX for spurious gene calls is to search it
with a database of HMMs built to detect some of the most popular spurious
gene calls – AntiFam. These models should be used to check both
COMBREX genes with evidence and GLIMMER’s candidate missed genes.
Authors’ response: We thank the reviewer for bringing AntiFam to our attention.
We used AntiFam to check both the named missed genes as well as the
hypothetical missed genes; 8 of the 13614 (0.06%) named missed genes were
found to be spurious genes, as were 141 of the 39003 (0.36%) hypothetical
missed genes. We have added discussion of this to the manuscript and a new
table summarizing the results.
The statement that a gene has evidence is very different from the statement
that the full length of a gene has evidence. Thus, a spurious ORF from one
genome could be compared to a real gene, with an improper 5’-extension,
from another genome. The COMBLAST pipeline would provide evidence in
support for adding the gene, and naming it, when that action might be
inappropriate.
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such occurrences by only considering genes to be similar if the alignment
between the two covers at least 80% of the gene in COMBREX. As the reviewer
mentioned earlier, 5’ annotation remains a more challenging problem than
gene identification, and the lower accuracy of start codon annotation
compared to gene annotation should be taken into account by anyone using
ComBlast, or any gene finding/annotation tool. We do not claim that every
missed gene identified is necessarily correctly called as a gene and associated
with a name, but only that it has good evidence to support that it is a true
gene. Further analysis and checking may need to be performed to confirm each
gene's validity.
The paper makes no mention that NCBI provides RefSeq versions of
genomes, produced by a pipeline that is applied pretty consistently. The
purpose of RefSeq is to compensate for the fact that submitted genomes
are largely archival documents, not maintained with respect to functional
annotation and only infrequently modified to correct previous gene-calling
errors. Thus, genes missing from GenBank are not equivalent to genes
missing from the accessible world of searchable protein sequences.
Authors’ response: While annotations of genomes in RefSeq are provided by
NCBI, many of these are still listed as “provisional”, meaning that they have not
been manually reviewed by NCBI staff. For prokaryotic genomes, the annotation
present in RefSeq is based heavily on the GenBank annotation if one is provided
[14]. We have added a discussion on this, as well as a comparison of RefSeq
and GenBank annotations for ten genomes. In summary, although genes
missing from GenBank are not necessarily missing from RefSeq, a sample of
missed genes from GenBank we found were also missing from RefSeq.
Reviewer 2: Dr. Arcady Mushegian
The study by Wood et al. reports the results of re-prediction, by Glimmer3, of
the open reading frames in the majority of finished bacterial genomes and
identifying such of these genes that have been missed by earlier genome
annotation efforts. The protein-level sequence similarity to the database
proteins is used as a criterion of the reality, which is further elaborated by
taking into account the experimental knowledge about the homologs of the
predicted gene products. The COMBREX database, which holds and curates
this knowledge, is discussed, and examples of database queries that have to
do with antibiotics resistance and gene essentiality and help guide
experiments are given. The study also collected statistics concerning missed
genes in genome annotations. For example, the average number of missed
conserved genes per annotated genome appears to be about 10, this
average varies between 2 and 13 depending on the sequencing center,
large sequencing centers are better than small teams - presumably, because
of the more robust annotation pipelines and better staffed bioinformatics
department - and genes missed by all centers tend to be on the shorter side
- evidently, in part because of the arbitrary length cutoffs imposed by many
genome annotation efforts.
COMBREX is a useful resource, set up in such a way as to involve the
scientific community in improving annotation of bacterial gene function.
This is worth highlighting. On the other hand, my perfunctory attempts to
find new predictions, i.e., previously missed but now restored to being,
genes by querying http://combrex.bu.edu/ failed - is there a way to do it,
and should it not be provided simultaneously with the submission of a
paper that talks about such genes?
Authors’ response: It is one of our goals to make sure that the new set of
missed genes will be accessible to the community. To insure that, we first
provide a webpage on COMBREX’s database website with all the missed genes,
including the ones that can be related to COMBREX genes. One can also query
the COMBREX database with a specific sequence using the ComBlast server
currently under development at http://scibaydev.bu.edu/ . We plan to develop
both the user interface and the tool itself so it will be as useful as possible to
general users. Finally, it is our intention to include the missed genes as part of
the COMBREX database. This way every missed gene will be available to queries
to the database.
A technical comment: on p. 4, we read: "For those candidate missed genes
with homology only to hypothetical proteins, we needed additional
information to determine if they were indeed genes." and again on p. 7: "it is
likely that a significant fraction of such genes [i.e., those passing three
reasonably restrictive filters, after sequence similarity has been established in
the first place - AM] are not true genes". In both cases, it is not clear to me
what the alternative to these ORFs being true genes may be - they could be
pseudogenes of course, but the authors address this separately. Then, on p.8, the authors suggest an alternative for the special case of very closely
related strains, when the conservation of a spurious ORF can be an artifact of
similar k-mer distribution (I suppose, even more trivially in this case, this
could be a result of very high overall nucleotide-level sequence similarity).
Right away, however, the authors remark that if an ORF is conserved in more
genomes, and, better yet, in several relatively diverse evolutionary lineages,
then it is most likely not spurious. But since the ORFs in question were
identified by sequence similarity in the first place, one would think that a
simple filter on the taxonomic closeness or even percent identity (not too
high in either case) would take care of the problem? More generally, and in
line with the authors' approach, it would be useful to have a rule of thumb
such as "an ORF with a homolog separated by evolutionary distance X has
an Y percent chance not to be spurious" - most likely, the authors already
have data on hand to address this?
Authors’ response: Although such filters would very likely solve the problem, we
wanted to be as sure as possible that the missed genes we considered as part
of our annotation center analysis were indeed true genes. To that end, we
elected to require the presence of a functional assignment to the gene, rather
than attempting to discover a percent identity threshold that was “conservative
enough” to give us a similar confidence in a gene’s coding nature.
p. 8 and Table 1: replace "significant homology" with "significant similarity".
Authors’ response: We have made these changes, and thank the reviewer for
bringing them to our attention.
Quality of written English: Acceptable
Reviewer 3: Dr. M. Pilar Francino (nominated by Prof. David Ardell)
This work reports an interesting reanalysis of gene annotation in bacterial
genomes, revealing that, although the great majority of genes are found in
every genome, a large number of very likely genes have been missed
overall. Many of these misses are due to overstringent cut offs in terms of
minimum gene length. The analysis also reveals that large genome centers
that rely on well established annotation pipelines miss fewer genes than
smaller centers and individual laboratories, suggesting that bioinformatics
expertise is another crucial factor in this issue. The missed genes are
separated by the authors into “named” and “hypothetical” groups and
further analysed using the new COMBREX database, which contains
functional and phenotypic gene information that has been gathered from
the experimental literature. This provides further support for the coding
nature of the candidate missed genes in the “named” group and for a
fraction of those in the “hypothetical” group. Moreover, a specific level of
support is assigned to every gene annotation depending on the type of
COMBREX information associated with it. Overall, the paper is an important
attention call on the need to homogenize annotation procedures as well as
a demonstration of how knowledge bases such as COMBREX can facilitate
and improve gene annotation. It is extremely well written and easy to follow.
Quality of written English: Acceptable
Authors’ response: We thank the reviewer for her kind comments.
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